Short answer
SOLESENCE, INC. (SLSN) filed its Q2 2026 10-Q quarterly report on Aug 19, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $15M (down 24.7% year over year) with net income of −$354,000.
Q2 2026 key financials · XBRL
- Revenue
- $15M
- −24.7% YoY · +18.3% QoQ
- Net income
- −$354,000
- −113.3% YoY · +53.8% QoQ
- Operating margin
- -0.5%
- Gross margin
- 29.7%
- EPS (diluted)
- −$0.01
- −125.0% YoY · +0.0% QoQ
Source: XBRL data from the SOLESENCE, INC. (SLSN) Q2 2026 10-Q on SEC EDGAR. USD.
SOLESENCE, INC. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $15,332, down from $20,359 YoY, primarily due to lower product sales
- Cost of revenue 68.8% vs 68.4% YoY, based on $10,548 and $15,332 revenue
- Consumer Products largest category, customer 1 at 58% of revenue; Personal Care Ingredients weakest at 1%
- Cash $1,046 vs $4,108; operating cash flow $1,708 vs $(7,875) YoY
- 2026 capital spending expected at $0.5 million–$1.5 million; inflation and supplier price increases potential headwinds
Risk Factors
- No quarterly risk-factor disclosure; company identifies as a smaller reporting company
- No new regulatory, legal, operational, competitive, market, liquidity, debt, currency, or concentration risks disclosed
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other SOLESENCE, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.